Hyperuricemia in psoriatic arthritis: clinical correlations and implications
Clinical Rheumatology · 2025
DOI: 10.1007/s10067-025-07400-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Rheumatology, 2025. Verfasst von Samar AbdAlhamed Tabra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Rehabilitation, Faculty of Medicine, Tanta University, El-Geish Street, Tanta, 31527, Gharbia, Egypt. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Hyperuricemia, Uric Acid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tanta University.
Abstract (Originalsprache)
Background
Psoriatic arthritis (PsA) patients may have elevated serum uric acid levels, and hyperuricemia may impact the degree of inflammation and clinical disease severity. Objectives comparison between PsA patients with and without hyperuricemia and assessment of the effect of hyperuricemia on clinical presentation, disease activity, disease severity, and associated comorbidities in PsA patients.
Methods
76 PsA patients with hyperuricemia and 74 PsA patients with normal uric acid as control were included. Demographic, clinical, comorbidities, and laboratory data were collected. Hyperuricemia threshold ≥ 60 mg/L.
Results
There were no significant differences between patients with and without hyperuricemia regarding gender, PsA articular subtype, PASI score, and treatment received, while patients with hyperuricemia were older (40.47 ± 8.53 vs 34.59 ± 7.29, p = 0.0001), had more comorbidity, higher body mass index (BMI) (28.49 ± 2.07 vs 26.91 ± 1.63kg/m2, p = 0.0001), DAPSA score (16.75 ± 7.04 vs 9.32 ± 6.35, p = 0.0001), ESR (34.78 ± 7.12 vs 28.55 ± 8.97, p = 0.0001), CRP (11.42 ± 3.23 vs 8.68 ± 4.04, p = 0.0001), serum cholesterol (220.42 ± 46.83 vs 169.82 ± 37.82, p = 0.0001), and triglycerides (136.47 ± 36.4 vs 104.89 ± 22.15, p = 0.0001), and longer duration of Psoriasis and PsA. The serum uric acid levels were significantly positively correlated with age, duration of Psoriasis, duration of PsA, BMI, CRP, ESR, DAPSA, and PASI score. Multivariate analysis showed that male sex, BMI, and increased disease activity were independent predictors of hyperuricemia in PsA patients.
Conclusion
Psoriatic arthritis patients with hyperuricemia have higher age, BMI, disease activity, and more associated comorbidities. In PsA patients, hyperuricemia was associated with male sex, BMI, and increased disease activity, but not associated with PASI score. Key Points • Psoriasis, PsA, and hyperurice s is a bi-centric case–control retrospective of cardiovascular disease. • Male gender, BMI, and increased disease activity were independent predictors of hyperuricemia in PsA patients. • Psoriatic arthritis patients with hyperuricemia have been more associated with comorbidities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Rehabilitation, Faculty of Medicine, Tanta University, El-Geish Street, Tanta, 31527, Gharbia, Egypt.
- Rheumatology and Rehabilitation Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
- Rheumatology and Rehabilitation Department, Faculty of Medicine, Al-Azhar University, Damietta, Egypt.
- Department of Rheumatology and Rehabilitation, Faculty of Medicine, Tanta University, El-Geish Street, Tanta, 31527, Gharbia, Egypt. drmhassan113@yahoo.com.
Förderung
- Tanta University
Zitieren
APA
Tabra, S. A., Aly, H. M., Ghanem, S., & Abu-Zaid, M. H. (2025). Hyperuricemia in psoriatic arthritis: clinical correlations and implications. Clinical Rheumatology. https://doi.org/10.1007/s10067-025-07400-4
Vancouver
Tabra SA, Aly HM, Ghanem S, Abu-Zaid MH. Hyperuricemia in psoriatic arthritis: clinical correlations and implications. Clinical Rheumatology. 2025. doi:10.1007/s10067-025-07400-4
BibTeX
@article{Tabra2025,
author = {Tabra, Samar AbdAlhamed and Aly, Hany M and Ghanem, Saad and Abu-Zaid, Mohammed Hassan},
title = {Hyperuricemia in psoriatic arthritis: clinical correlations and implications},
journal = {Clinical Rheumatology},
year = {2025},
doi = {10.1007/s10067-025-07400-4}
}
EUVIMED